Predictions
LM Funding America Inc.
Start price
Target price
Perf. (%)
€9.00
12.01.21
12.01.21
-
12.01.22
12.01.22
-56.44%
13.01.22
13.01.22
Stable Large shareholder and/or long term investor
Dependend from some customers or products
Little innovation
Probably not worthwhile Investment
3D Systems Corp.
Start price
Target price
Perf. (%)
€22.77
12.01.21
12.01.21
€50.00
12.01.22
12.01.22
2.00%
09.10.21
09.10.21
Could be very worthwhile Investment >20% year
Salesforce.com
Start price
Target price
Perf. (%)
€180.92
11.01.21
11.01.21
-
11.01.22
11.01.22
2.96%
25.01.21
25.01.21
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Fair valuation
Very Future proof/growth oriented business model
Mastercard Inc. A
Start price
Target price
Perf. (%)
€289.25
11.01.21
11.01.21
€340.00
11.01.22
11.01.22
11.93%
12.01.22
12.01.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
3D Systems Corp.
Start price
Target price
Perf. (%)
€20.00
11.01.21
11.01.21
€50.00
11.01.22
11.01.22
13.83%
12.01.21
12.01.21
Could be very worthwhile Investment >20% year
Stratasys Inc.
Start price
Target price
Perf. (%)
€24.14
11.01.21
11.01.21
€50.00
11.01.22
11.01.22
-5.59%
09.10.21
09.10.21
Could be very worthwhile Investment >20% year
PolarityTE Inc.
Start price
Target price
Perf. (%)
€32.25
11.01.21
11.01.21
-
11.01.22
11.01.22
-41.09%
27.01.21
27.01.21
Could be worthwhile Investment >10% per year
Good culture
Innovative
Few uniques
Asensus Surgical Inc.
Start price
Target price
Perf. (%)
€1.72
11.01.21
11.01.21
-
11.01.22
11.01.22
40.70%
19.01.21
19.01.21
Capable Management
Good culture
Dependend from some customers or products
LM Funding America Inc.
Start price
Target price
Perf. (%)
€15.10
11.01.21
11.01.21
-
11.01.22
11.01.22
-73.38%
12.01.22
12.01.22
Could be worthwhile Investment >10% per year
Anavex Life Sciences Corp
Start price
Target price
Perf. (%)
€4.60
11.01.21
11.01.21
€6.00
11.01.22
11.01.22
10.87%
25.01.21
25.01.21
Could be worthwhile Investment >10% per year
Lumos Pharma Inc.
Start price
Target price
Perf. (%)
€18.00
11.01.21
11.01.21
€25.00
11.01.22
11.01.22
-17.22%
25.01.21
25.01.21
Could be worthwhile Investment >10% per year
Evolus Inc
Start price
Target price
Perf. (%)
€3.62
11.01.21
11.01.21
€4.00
77.53%
25.01.21
25.01.21
Could be worthwhile Investment >10% per year
Nuwellis Inc.
Start price
Target price
Perf. (%)
€6.40
11.01.21
11.01.21
€8.00
17.97%
25.01.21
25.01.21
Could be very worthwhile Investment >20% year
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€0.79
11.01.21
11.01.21
€2.00
11.01.22
11.01.22
166.14%
25.01.21
25.01.21
Could be worthwhile Investment >10% per year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€22.25
11.01.21
11.01.21
€75.00
11.01.22
11.01.22
65.17%
25.01.21
25.01.21
Could be worthwhile Investment >10% per year
Starbucks Corp.
Start price
Target price
Perf. (%)
€87.00
11.01.21
11.01.21
€99.00
11.01.22
11.01.22
23.33%
27.07.21
27.07.21
Could be worthwhile Investment >10% per year
Good culture
Future proof or reliable business model
Market Leader or Top 3
Plug Power Inc.
Start price
Target price
Perf. (%)
€42.23
11.01.21
11.01.21
€60.00
11.01.22
11.01.22
-38.47%
04.01.22
04.01.22
Small cyclical dependencies
Known brand
Capable Management
Top 10 in its market
Uranium Energy Corp
Start price
Target price
Perf. (%)
€1.68
11.01.21
11.01.21
-
11.01.22
11.01.22
-12.47%
22.01.21
22.01.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Leggett & Platt Inc.
Start price
Target price
Perf. (%)
€35.80
11.01.21
11.01.21
-
11.01.22
11.01.22
11.12%
18.10.21
18.10.21
EBIT growth >5% per year expected
High dividend yield expected
Revenue growth >5% per year expected
FutureFuel Corp.
Start price
Target price
Perf. (%)
€11.10
10.01.21
10.01.21
€20.00
10.01.22
10.01.22
-33.78%
11.01.22
11.01.22
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Federal Realty Investment Trust
Start price
Target price
Perf. (%)
€69.53
10.01.21
10.01.21
-
10.01.22
10.01.22
29.50%
20.04.21
20.04.21
Very high dividend yield expected
High valuation
Revenue decline/stagnation expected
Acelrx Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.74
10.01.21
10.01.21
-
10.01.22
10.01.22
39.88%
23.01.21
23.01.21
Risky Investment
StoneMor Inc.
Start price
Target price
Perf. (%)
€2.22
10.01.21
10.01.21
-
10.01.22
10.01.22
20.72%
23.01.21
23.01.21
Risky Investment
Cal-Maine Foods Inc.
Start price
Target price
Perf. (%)
€30.80
10.01.21
10.01.21
-
10.01.22
10.01.22
14.94%
11.01.22
11.01.22
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Future proof or reliable business model
Strong uniques